CCL2 and prostate cancer: Although several chemokines are capable of recruiting TAMs to the TME [9], the chemoattractant C-C motif ligand 2 (CCL2), alias MCP1, is the key factor and is known to be induced in prostate cancer in response to AR inhibition [10,11].